XML 88 R25.htm IDEA: XBRL DOCUMENT
v3.25.3

Licensing, Acquisitions and Other Arrangements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Licensing, Acquisitions, and Other Arrangements |
Schedule of Research and Development Assets Acquired Other than Through Business Combination | The following table summarizes acquired IPR&D and milestones expense:
|  | Three months ended September 30, |  | Nine months ended September 30,
(in millions) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Upfront charges |  | $ | 2,615 |  |  | $ | 82 |  |  | $ | 3,566 |  |  | $ | 1,088 |
Development milestones |  | 65 |  |  | — |  |  | 185 |  |  | 95 |
Acquired IPR&D and milestones |  | $ | 2,680 |  |  | $ | 82 |  |  | $ | 3,751 |  |  | $ | 1,183 |

X
- References No definition available. + Details
Name: | abbv_AcquisitionsCollaborationsAndOtherArrangementsDisclosureAbstract
Namespace Prefix: | abbv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of capitalized cost and amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1 + Details
Name: | us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration